Enalapril and renal function in hypertensive rats transgenic for mouse renin gene

Hypertension

Volumn 30, Issue 4, 1997, Pages 868-872

  Springate, James E ^a   Feld, Leonard G ^b   Ganten, Detlev ^b  

^a CHILDREN S HOSPITAL OF BUFFALO   (United States)

^b NONE

Author keywords

Albuminuria; Glomerulosclerosis; Nitric oxide

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; NITRIC OXIDE;

ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; GLOMERULOSCLEROSIS; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRANSGENIC MOUSE; URINE FLOW RATE;

EID: 0030774842     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.4.868     Document Type: Article

References (25)

1. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse ren-2 gene. Nature. 1990;344: 541-544.
2. Bader M, Zhao Y, Sander M, Lee M, Bachmann J, Bohm M, Djavidani B, Peters J, Mullins J, Ganten D. Role of tissue renin in the pathophysiology of hypertension in TGR(mRen2)27 rats. Hypertension. 1992;19:681-686.
3. Rapp J. Use and misuse of control strains for genetically hypertensive rats. Hypertension. 1987;10:7-10.
4. Springate J, Feld L, Ganten D. Renal function in hypertensive rats transgenic for mouse renin gene. Am J Physiol. 1994;266: F731-F737.
5. Feld L, Cachero S, Ellis E, Dedeoglu O, Ueda Y, Leonard C, Letizia R, Mallon V, Van Liew J. Resistance to glomerular injury in the diabetic biobreeding rat. Exp Physiol, 1995;80:991-1000.
6. Feld L, Van Liew J, Brentjens J, Boylan J. Renal lesions and proteinuria in the spontaneously hypertensive rat made normotensive by treatment. Kidney Int. 1981;20:606-614.
7. Komatsu K, Frohlich E, Ono H, Ono Y, Numabe A, Willis G. Glomerular dynamics and morphology of aged spontaneously hypertensive rats. Hypertension. 1995;25:207-213.
8. Lee M, Bohm M, Kim S, Bachmann S, Bachmann J, Bader M, Ganten D. Differential gene expression of renin and angiotensinogen in the TGR(mRen2)27 transgenic rat. Hypertension. 1995; 25:570-580.
9. Hollenberg N, Fisher N. Renal circulation and blockade of the renin-angiotensin system. Hypertension. 1995;26:602-609.
10. Suto T, Losonczy G, Qiu C, Hill C, Samsell L, Ruby J, Charon N, Venuto R, Baylis C. Acute changes in urinary excretion of nitrite + nitrate do not necessarily predict renal vascular NO production. Kidney Int. 1995;48:1272-1277.
11. Boger R, Bode-Boger S, Gerecke U, Gutzki F, Tsikas D, Frolich J. Urinary NO3 - excretion as an indicator of nitric oxide formation in vivo during oral administration of L-arginine or L-NAME in rats. Clin Exp Pharmacol Physiol. 1996;23:11-15.
12. Bachmann S, Peters J, Engler E, Ganten D, Mullins J. Transgenic rats carrying the mouse renin gene - morphological characterization of a low-renin hypertension model. Kidney Int. 1992;41: 24-36.
13. Bohm M, Lee M, Kreutz R, Kim S, Schinke M, Djavidani B, Wagner J, Kaling M, Wienen W, Bader M, Ganten D. Angiotensin II receptor blockade in TGR(mRen2)27: effects on renin-angiotensin system gene expression and cardiovascular functions. J Hypertens. 1995;13:891-899.
14. Hirth-Dietrich C, Stasch J, Ganten D, Luft F. Renal effects of captopril and nitrendipine in transgenic rats with an extra renin gene. Hypertension. 1994;23:626-631.
15. Campbell D, Rong P, Kladis A, Rees B, Ganten D, Skinner S. Angiotensin and bradykinin peptides in the TGR(mRen2)27 rat. Hypertension. 1995;25:1014-1020.
16. Gross V, Lippoldt A, Schneider W, Luft F. Effect of captopril and angiotensin II receptor blockade on pressure-natriuresis in transgenic TGR(mRen2)27 rats. Hypertension. 1995;26:471-479.
17. Mitchell K, Mullins J. Ang II dependence of tubuloglomerular feedback responsiveness in hypertensive ren-2 transgenic rats. Am J Physiol. 1995;268:F821-F828.
18. Gross V, Roman R, Cowley A. Abnormal pressure-natriuresis in transgenic renin gene rats. J Hypertens. 1994;12:1029-1034.
19. Buckalew VM. Pathophysiology of progressive renal failure. South Med J. 1994;87:1028-1033.
20. Feld L, Zamlauski-Tucker M, Springate J, Van Liew J. Single nephron hemodynamics in spontaneously hypertensive rats. Proc Soc Exp Biol Med. 1995;209:185-189.
21. Heudes D, Michel O, Chevalier J, Scalbert E, Ezan E, Bariety J, Zimmerman A, Corman B. Effect of chronic ANG I-converting enzyme inhibition on aging processes, I: kidney structure and function. Am J Physiol. 1994;266:R1038-R1051.
22. Ferder L, Inserra F, Romano L, Ercole L, Pszenny V. Decreased glomerulosclerosis in aging by angiotensin-converting enzyme inhibitors. J Am Soc Nephrol. 1994;5:1147-1152.
23. Remuzzi A, Imberti O, Puntorieri S, Malanchini B, Macconi D, Magrini L, Bertani T, Remuzzi G. Dissociation between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in rats. Am J Physiol. 1994;267:F1034-F1044.
24. Ruiz-Ortega M, Gonzalez S, Seron D, Condom E, Bustos C, Largo R, Gonzalez E, Ortiz A, Egido J. ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. Kidney Int. 1995;48:1778-1791.
25. Feld L, Cachero S, Van Liew J, Zamlauski-Tucker M, Noble B. Enalapril and renal injury in spontaneously hypertensive rats. Hypertension. 1990;16:544-554.